Healthcare
Surgery Partners, Inc.(SGRY)
Live Price
Offline$15.31
+2.48% today
1Y Change
-21.61%
Window
Jun 20, 2025 โ Jun 15, 2026
- Market Cap
- $1.85B
- Revenue Growth
- +6.2%
- EPS Growth
- +54.1%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 20, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Surgery Partners, Inc. (SGRY) is a Healthcare stock with a market cap of $1.85B and listed on NASDAQ. The stock last traded around $15.31 and down 21.6% across the available one-year price window (Jun 20, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +6.2%, EPS growth of +54.1%, a dividend yield of 0.0%. What stands out right now is revenue +6.2%, EPS +54.1%, free cash flow -6.7% with operating margin 11.8% and ROIC 4.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.6. Stock Foundry combines SGRY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+6.2% vs +7.6% peer median
Operating Margin
Below sector median
+11.8% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +6.2% and EPS at +54.1%, with operating margin around 11.8%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -7.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | +1.4% | +1.0% | +1.3% |
2026 Mar 2, 2026 | -61.3% | -12.3% | -16.2% | -27.0% |
2025 Nov 10, 2025 | -31.6% | -1.8% | -6.1% | +8.5% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SGRY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SGRY Max Drawdown
-51.80%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SGRY and SPY.
Company Overview
Surgery Partners, Inc.
NASDAQ Global Select
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
- Leadership
- J. Eric Evans
- IPO Date
- Sep 30, 2015
- Employees
- 15.0k
- Street Address
- 310 Seven Springs Way
- Mailing
- Brentwood, TN, 37027
- Region
- Brentwood, TN, US
- Reporting Currency
- USD
- Investor Line
- 615 234 5900
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 5.9
- Price/Sales
- 0.6
- Price/Book
- 1.1
Growth
- Revenue
- +6.2%
- EPS
- +54.1%
- Free Cash Flow
- -6.7%
Profitability
- Gross Margin
- 23.1%
- Operating Margin
- 11.8%
- Net Margin
- -2.4%
- ROE
- -4.5%
- ROIC
- 4.2%
Balance Sheet
- Debt/Equity
- 2.35
- Current Ratio
- 1.87
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.